Volk Susan W, Iqbal Syed Amir, Bayat Ardeshir
Departments of Clinical Studies and Animal Biology, University of Pennsylvania School of Veterinary Medicine , Philadelphia, Pennsylvania.
Plastic and Reconstructive Surgery Research, Manchester Institute of Biotechnology, University of Manchester , Manchester, United Kingdom .
Adv Wound Care (New Rochelle). 2013 Jul;2(6):261-272. doi: 10.1089/wound.2012.0417.
Both chronic wounds and excessive scar formation after cutaneous injury create a formidable clinical problem resulting in considerable morbidity and healthcare expenditure. The deposition and remodeling of extracellular matrix (ECM) components are critical processes in cutaneous healing. Understanding the role of the ECM in directing progenitor and reparative cell fate and activities during wound repair is required to improve wound-care strategies.
In addition to providing structural integrity, the ECM is recognized to play critical roles in regulating progenitor and reparative cell behaviors such as migration, differentiation, proliferation, and survival. The ECM dictates these activities through its binding of adhesion receptors as well as its ability to regulate growth factor bioavailability and signaling. More recently, a key role for mechanical control of cell fate through interaction with the ECM has emerged.
Despite significant advances in understanding the pathophysiology of cutaneous wound repair, problematic wounds remain a significant healthcare challenge. Regenerative medical strategies that either target endogenous stem cells or utilize applications of exogenous stem cell populations have emerged as promising approaches to pathologic wounds. However, the identification of smart biomaterials and matrices may allow for further optimization of such therapies.
An efficient and appropriate healing response in the skin postinjury is regulated by a fine balance of the quantity and quality of ECM proteins. A more complete understanding of ECM regulation of the cell fate and activities during cutaneous wound repair is vital for the development of novel treatment strategies for improvement of cutaneous healing.
慢性伤口和皮肤损伤后过度的瘢痕形成均造成了严峻的临床问题,导致相当高的发病率和医疗支出。细胞外基质(ECM)成分的沉积和重塑是皮肤愈合中的关键过程。为了改进伤口护理策略,需要了解ECM在伤口修复过程中指导祖细胞和修复细胞命运及活动方面的作用。
除了提供结构完整性外,ECM还被认为在调节祖细胞和修复细胞行为(如迁移、分化、增殖和存活)中起关键作用。ECM通过其与黏附受体的结合以及调节生长因子生物利用度和信号传导的能力来决定这些活动。最近,通过与ECM相互作用对细胞命运进行机械控制的关键作用已显现出来。
尽管在理解皮肤伤口修复的病理生理学方面取得了重大进展,但有问题的伤口仍然是重大的医疗挑战。针对内源性干细胞或利用外源性干细胞群体应用的再生医学策略已成为治疗病理性伤口的有前景的方法。然而,识别智能生物材料和基质可能会进一步优化此类疗法。
损伤后皮肤中有效且适当的愈合反应是由ECM蛋白的数量和质量的精细平衡来调节的。更全面地了解ECM在皮肤伤口修复过程中对细胞命运和活动的调节对于开发改善皮肤愈合的新治疗策略至关重要。